Louise Dalsager1, Nikolas Christensen2, Steffen Husby3, Henriette Kyhl4, Flemming Nielsen5, Arne Høst3, Philippe Grandjean6, Tina Kold Jensen7. 1. Department of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, J.B. Winsløwsvej 17A, 5000 Odense, Denmark; Rigshospitalet, Copenhagen University Hospital, Department of Growth and Reproduction, Blegdamsvej 9, 2100 Copenhagen, Denmark. Electronic address: ldalsager@health.sdu.dk. 2. Hans Christian Andersen Children's Hospital, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, Denmark; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. 3. Hans Christian Andersen Children's Hospital, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, Denmark. 4. Hans Christian Andersen Children's Hospital, Odense University Hospital, Sdr. Boulevard 29, 5000 Odense C, Denmark; Odense Patient data Exploratory Network (OPEN), Odense, Denmark. 5. Department of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, J.B. Winsløwsvej 17A, 5000 Odense, Denmark. 6. Department of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, J.B. Winsløwsvej 17A, 5000 Odense, Denmark; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 7. Department of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, J.B. Winsløwsvej 17A, 5000 Odense, Denmark; Rigshospitalet, Copenhagen University Hospital, Department of Growth and Reproduction, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Abstract
INTRODUCTION: Perfluorinated alkylated substances (PFAS) are persistent industrial chemicals that have resulted in global environmental exposures. Previous epidemiological studies have reported possible effects on the immune system after developmental PFAS exposure, but the possible impact on childhood infectious disease is unclear. OBJECTIVES: To investigate the association between prenatal exposure to PFAS and symptoms of infections at age 1-4years. METHODS: The Odense Child Cohort is an on-going prospective study on children's health, where serum concentrations of perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), perfluorodecanoic acid (PFDA) and perfluorononanoic acid (PFNA) were measured in 649 pregnant women before gestational week 16. Of these women, 359 reported on symptoms of infection in their child every two weeks for a one-year period. The association between prenatal exposure to PFAS and the symptoms was estimated using a logistic regression model and a negative binomial regression model. For the latter, the outcome was reported as an incidence rate-ratio (IRR), and all models were adjusted for maternal age, educational level, parity and child age. RESULTS: On average, the children experienced symptoms of infection 23% of the time during one year. PFOS exposure in the high tertile compared to the low tertile was associated with a statistically significant increased proportion of days with fever (IRR: 1.65 (95% CI: 1.24, 2.18), P-trend<0.001) and an increased odds of experiencing days with fever above the median (OR: 2.35 (95% CI: 1.31, 4.11). The latter tendency was also apparent for PFOA (OR: 1.97 (95% CI: 1.07, 3.62). Further, higher concentrations of PFOS and PFOA tended to increase the number of episodes of co-occurrence of fever and coughing and fever and nasal discharge during the one-year study period. CONCLUSION: We found a positive association between prenatal exposure to PFOS and PFOA and the prevalence of fever, which may be a sensitive marker of infection. This finding is in agreement with an immunotoxic effect of prenatal exposure to PFAS. The wider implications for childhood infectious disease deserve attention.
INTRODUCTION:Perfluorinated alkylated substances (PFAS) are persistent industrial chemicals that have resulted in global environmental exposures. Previous epidemiological studies have reported possible effects on the immune system after developmental PFAS exposure, but the possible impact on childhood infectious disease is unclear. OBJECTIVES: To investigate the association between prenatal exposure to PFAS and symptoms of infections at age 1-4years. METHODS: The Odense Child Cohort is an on-going prospective study on children's health, where serum concentrations of perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), perfluorodecanoic acid (PFDA) and perfluorononanoic acid (PFNA) were measured in 649 pregnant women before gestational week 16. Of these women, 359 reported on symptoms of infection in their child every two weeks for a one-year period. The association between prenatal exposure to PFAS and the symptoms was estimated using a logistic regression model and a negative binomial regression model. For the latter, the outcome was reported as an incidence rate-ratio (IRR), and all models were adjusted for maternal age, educational level, parity and child age. RESULTS: On average, the children experienced symptoms of infection 23% of the time during one year. PFOS exposure in the high tertile compared to the low tertile was associated with a statistically significant increased proportion of days with fever (IRR: 1.65 (95% CI: 1.24, 2.18), P-trend<0.001) and an increased odds of experiencing days with fever above the median (OR: 2.35 (95% CI: 1.31, 4.11). The latter tendency was also apparent for PFOA (OR: 1.97 (95% CI: 1.07, 3.62). Further, higher concentrations of PFOS and PFOA tended to increase the number of episodes of co-occurrence of fever and coughing and fever and nasal discharge during the one-year study period. CONCLUSION: We found a positive association between prenatal exposure to PFOS and PFOA and the prevalence of fever, which may be a sensitive marker of infection. This finding is in agreement with an immunotoxic effect of prenatal exposure to PFAS. The wider implications for childhood infectious disease deserve attention.
Authors: Kelsey E Barton; Anne P Starling; Christopher P Higgins; Carrie A McDonough; Antonia M Calafat; John L Adgate Journal: Int J Hyg Environ Health Date: 2019-08-20 Impact factor: 5.840
Authors: Rachel Rogers Worley; Susan McAfee Moore; Bruce C Tierney; Xiaoyun Ye; Antonia M Calafat; Sean Campbell; Million B Woudneh; Jeffrey Fisher Journal: Environ Int Date: 2017-06-20 Impact factor: 9.621
Authors: Richard Christian Jensen; Dorte Glintborg; Clara Amalie Gade Timmermann; Flemming Nielsen; Henriette Boye Kyhl; Hanne Frederiksen; Anna-Maria Andersson; Anders Juul; Johannes J Sidelmann; Helle Raun Andersen; Philippe Grandjean; Marianne S Andersen; Tina Kold Jensen Journal: Environ Res Date: 2019-12-31 Impact factor: 6.498
Authors: A Impinen; M P Longnecker; U C Nygaard; S J London; K K Ferguson; L S Haug; B Granum Journal: Environ Int Date: 2019-01-23 Impact factor: 9.621